EANS-Voting Rights: Marseille-Kliniken AG
Release according to article 26,
section 1 WpHG (Securities Trading Act) with the aim of Europe-wide distribution
-------------------------------------------------------------------------------- Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- Announcement according to Article 21, Section 1 of the WpHG (share) 1. DL Verwaltungs GmbH & Co. WP KG, Zirchow, Germany, has informed us on 17 November 2011 according to sec. 21, para. 1 of the WpHG that their share of voting rights in Marseille-Kliniken AG has exceeded the thresholds of 3%, 5%, 10%, 15%, 20%, 25% and 30% on 04 November 2011 and has amounted to 32.42% on this day. This is equivalent to 4,726,629 directly held voting rights of the overall 14,580,000 voting rights in Marseille-Kliniken AG. 2. DL-Holding GmbH, Zirchow, Germany, has informed us on 17 November 2011 according to sec. 21, para. 1 of the WpHG that their share of voting rights in Marseille-Kliniken AG has exceeded the thresholds of 3%, 5%, 10%, 15%, 20%, 25% and 30% on 04 November 2011 and has amounted to 32.42% on this day. This is equivalent to 4,726,629 attributed voting rights of the overall 14,580,000 voting rights in Marseille-Kliniken AG. Of these voting rights, 32.42% (4,726,629 voting rights) are attributed to DL-Holding GmbH pursuant to sec. 22 para. 1 sentence 1 no. 1 WpHG in connection with sec. 22 para. 3 WpHG from DL Verwaltungs GmbH & Co. WP KG, which is a subsidiary of DL-Holding GmbH. Further inquiry note: Contact Marseille-Kliniken AG: Andreas Sielemann General Representative Sportallee 1 22335 Hamburg Germany Tel.: +49-(0)40-51459-0 www.marseille-kliniken.com end of announcement euro adhoc -------------------------------------------------------------------------------- issuer: Marseille-Kliniken AG Alte Jakobstraße 79/80 D-10179 Berlin phone: +49 (0)30 246 32-400 FAX: +49 (0)30 246 32-401 mail: info@marseille-kliniken.de WWW: http://www.marseille-kliniken.de sector: Pharmaceuticals ISIN: DE0007783003 indexes: CDAX, Classic All Share, Prime All Share stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Stuttgart, Düsseldorf, regulated dealing: Hamburg language: English
Original-Content von: Marseille-Kliniken AG, übermittelt durch news aktuell